South Korea’s Samsung BioLogics reported a 56% jump in sales to $420 million (KRW 459.8 billion) for 2017, which the company attributes to boosts from two of its manufacturing facilities.Original Article
Samsung BioLogics reports $420M in sales for 2017, helped by production boosts from new plants
